Anagenics Limited (ASX:AN1)

Anagenics Statistics

Total Valuation

Anagenics has a market cap or net worth of AUD 5.91 million. The enterprise value is 6.37 million.

Market Cap	5.91M
Enterprise Value	6.37M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Anagenics has 985.45 million shares outstanding. The number of shares has increased by 17.65% in one year.

Current Share Class	985.45M
Shares Outstanding	985.45M
Shares Change (YoY)	+17.65%
Shares Change (QoQ)	+143.99%
Owned by Insiders (%)	9.01%
Owned by Institutions (%)	n/a
Float	624.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.16
PB Ratio	3.24
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.15
EV / Sales	1.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.46.

Current Ratio	0.89
Quick Ratio	0.44
Debt / Equity	0.46
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-23.38

Financial Efficiency

Return on equity (ROE) is -54.48% and return on invested capital (ROIC) is -19.23%.

Return on Equity (ROE)	-54.48%
Return on Assets (ROA)	-11.50%
Return on Invested Capital (ROIC)	-19.23%
Return on Capital Employed (ROCE)	-49.51%
Weighted Average Cost of Capital (WACC)	4.04%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.99
Inventory Turnover	2.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.00% in the last 52 weeks. The beta is -0.03, so Anagenics's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	-25.00%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	56.29
Average Volume (20 Days)	1,044,157

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Anagenics had revenue of AUD 5.12 million and -1.24 million in losses. Loss per share was -0.00.

Revenue	5.12M
Gross Profit	2.41M
Operating Income	-946,982
Pretax Income	-1.24M
Net Income	-1.24M
EBITDA	-746,584
EBIT	-946,982
Loss Per Share	-0.00

Balance Sheet

The company has 395,519 in cash and 848,052 in debt, with a net cash position of -452,533 or -0.00 per share.

Cash & Cash Equivalents	395,519
Total Debt	848,052
Net Cash	-452,533
Net Cash Per Share	-0.00
Equity (Book Value)	1.83M
Book Value Per Share	0.00
Working Capital	-250,874

Cash Flow

Operating Cash Flow	-1.58M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 47.08%, with operating and profit margins of -18.50% and -24.14%.

Gross Margin	47.08%
Operating Margin	-18.50%
Pretax Margin	-24.14%
Profit Margin	-24.14%
EBITDA Margin	-14.59%
EBIT Margin	-18.50%
FCF Margin	n/a

Dividends & Yields

Anagenics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.65%
Shareholder Yield	-17.65%
Earnings Yield	-20.90%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 27, 2017. It was a reverse split with a ratio of 0.05.

Last Split Date	Nov 27, 2017
Split Type	Reverse
Split Ratio	0.05

Scores

Anagenics has an Altman Z-Score of -21.02 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-21.02
Piotroski F-Score	2